Victor Hugo Ovani Marchetti

Real-world treatment patterns and healthcare utilization following omalizumab initiation in chronic spontaneous urticaria: a nationwide Brazilian cohort study

Abstract Chronic spontaneous urticaria (CSU) is a relapsing inflammatory skin disease associated with substantial symptom burden and repeated healthcare use. Omalizumab is recommended for patients whose disease remains uncontrolled despite second-generation H1-antihistamines, yet...